Clinical Trial Update: TY800 Dose Escalation (Typhoid) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports TY800 dose escalation for typhoid; the Phase 1/Phase 2 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paratyphoid Fever
• Typhoid Fever

Drugs mentioned

• Ty800

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Typhoid and Paratyphoid Fevers | Phase 1, Phase 2 | Status: COMPLETED